Corridor Pharmaceuticals corridorpharma.com

Corridor Pharmaceuticals, formerly Arginetix, is a platform-based pulmonary and critical care company focused on developing therapeutics to treat inflammation, fibrosis and endothelial dysfunction. Utilizing their platform technology, the Company has discovered a highly potent, small molecule approach to inhibiting arginase. Corridor is targeting diseases where elevated arginase levels have been shown to be involved in disease progression such a pulmonary fibrosis, COPD and ischemia reperfusion ...Show all

Corridor Pharmaceuticals, formerly Arginetix, is a platform-based pulmonary and critical care company focused on developing therapeutics to treat inflammation, fibrosis and endothelial dysfunction. Utilizing their platform technology, the Company has...Show all

See All Exits Recent Exits

Phone: 410-616-0916

Fax:

1122 Kenilworth Drive
Suite 401
Towson, 21204
Maryland, United States

Corridor Pharmaceuticals - Investments & Acquisitions

Show Real Data Corridor Pharmaceuticals Investments
See all Recent Investments
Date Company Round Amount Co-investors
2010-06-17ArginetixMerger
2010-06-17Immune ControlMerger
See all 2 investments